Latest AI and machine learning research in asthma for healthcare professionals.
Artificial intelligence (AI), first defined in 1955 by John McCarthy, has transformed daily life across industries through applications such as chatbots, autonomous vehicles, and navigation systems. The 2022 release of ChatGPT marked a pivotal moment, highlighting AI's rapidly expanding potential. The health care industry is increasingly embracing AI-enabled tools across oncology, pathology, and r...
OBJECTIVE: Long COVID (LC) remains poorly understood, and there is a critical need for advanced computational tools to better identify and characterize patients. In this study, we use summarized symptom reports by RECOVER-Adult cohort participants linked to EHR data to characterize patients and train a computable phenotype algorithm of LC. MATERIALS AND METHODS: The study included adult participan...
Asthma caused around 436,000 deaths globally in 2021. Predicting asthma attacks can save lives, reduce costs, and strengthen healthcare systems. Howev...
Asthma exhibits significant clinical heterogeneity, necessitating precise phenotyping for personalized treatment. This study aims to develop and inter...
Severe asthma remains a major unmet clinical challenge due to its marked immunological heterogeneity and the limited efficacy of current therapies in ...
The relative retention of nitrogen (N) and phosphorus (P) in lakes and their roles in nutrient cycling remain debated. Although the United States has ...
The deepening cyber-physical integration of smart grids has expanded the attack surface of power networks, while centralised intrusion detection schem...
To assess the feasibility of an electronic nose (e-nose) for volatile organic compounds (VOCs) to classify respiratory diseases and establish a protoc...
BACKGROUND: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common critical illness in the intensive care unit (ICU) and is ...
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are among the most prevalent chronic respiratory diseases worldwide, affecting hundreds of mil...
Chronic respiratory diseases represent a leading cause of global mortality, yet robust prediction tools integrating onset risk and long-term prognosis...
BACKGROUND: Asthma is a common chronic inflammatory airway disease. Accumulating evidence highlights the roles of demographic, lifestyle, and comorbid...
BACKGROUND: Asthma-COPD overlap (ACO) remains poorly characterized at the molecular level, leading to diagnostic uncertainty and suboptimal treatment....
BACKGROUND: The integration of artificial intelligence (AI) into clinical research challenges traditional informed consent (IC) frameworks due to the ...
PURPOSE OF REVIEW: While pharmacologic and device therapies have improved heart failure care in recent decades, age-adjusted rehospitalization rates r...
Childhood allergic asthma (CAA) is a chronic airway inflammatory disorder driven by allergens, and its underlying molecular mechanisms as well as prec...
Asthma is a chronic inflammatory airway disease characterized by barrier dysfunction and excessive inflammatory response. In this study, we identified...
OBJECTIVE: To examine UK general practitioners' (GPs) adoption of ambient artificial intelligence (AI) scribes and to assess user-reported error rates...
PURPOSE OF REVIEW: The review examines the application of machine learning (ML) and large language models (LLMs) to asthma management. We sought to id...
BACKGROUND: Artificial intelligence (AI) is emerging as a critical tool for nurse practitioners delivering pediatric and adolescent and young adult (A...